vs
American Assets Trust, Inc.（AAT）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
American Assets Trust, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$110.6M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 1.8%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -0.1%）
该公司是一家大型英国投资信托，在伦敦证券交易所上市，同时是富时250指数的成分股，现任董事长为获颁CBE勋章的伊恩·弗格森。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
AAT vs PBYI — 直观对比
营收规模更大
AAT
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出25.9%
1.8%
两年增速更快
PBYI
近两年复合增速
-0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $110.6M | $75.5M |
| 净利润 | $6.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 23.4% | 22.7% |
| 净利率 | 6.1% | — |
| 营收同比 | 1.8% | 27.7% |
| 净利润同比 | -16.3% | — |
| 每股收益（稀释后） | $0.08 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AATPBYI
| Q1 26 | $110.6M | — | ||
| Q4 25 | $110.1M | $75.5M | ||
| Q3 25 | $109.6M | $54.5M | ||
| Q2 25 | $107.9M | $52.4M | ||
| Q1 25 | $108.6M | $46.0M | ||
| Q4 24 | $113.5M | $59.1M | ||
| Q3 24 | $122.8M | $80.5M | ||
| Q2 24 | $110.9M | $47.1M |
净利润AATPBYI
| Q1 26 | $6.7M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $4.5M | $8.8M | ||
| Q2 25 | $5.5M | $5.9M | ||
| Q1 25 | $42.5M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $16.7M | $20.3M | ||
| Q2 24 | $11.9M | $-4.5M |
毛利率AATPBYI
| Q1 26 | — | — | ||
| Q4 25 | 59.4% | 69.3% | ||
| Q3 25 | 60.5% | 77.7% | ||
| Q2 25 | 62.6% | 76.5% | ||
| Q1 25 | 62.0% | 77.1% | ||
| Q4 24 | 61.3% | 76.4% | ||
| Q3 24 | 65.5% | 63.9% | ||
| Q2 24 | 63.6% | 77.4% |
营业利润率AATPBYI
| Q1 26 | 23.4% | — | ||
| Q4 25 | 21.1% | 22.7% | ||
| Q3 25 | 22.6% | 17.6% | ||
| Q2 25 | 24.1% | 12.7% | ||
| Q1 25 | 66.3% | 8.7% | ||
| Q4 24 | 26.5% | 22.6% | ||
| Q3 24 | 30.8% | 27.4% | ||
| Q2 24 | 27.8% | -4.6% |
净利率AATPBYI
| Q1 26 | 6.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 4.1% | 16.2% | ||
| Q2 25 | 5.1% | 11.2% | ||
| Q1 25 | 39.2% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 13.6% | 25.2% | ||
| Q2 24 | 10.7% | -9.6% |
每股收益（稀释后）AATPBYI
| Q1 26 | $0.08 | — | ||
| Q4 25 | $0.06 | $0.26 | ||
| Q3 25 | $0.07 | $0.17 | ||
| Q2 25 | $0.09 | $0.12 | ||
| Q1 25 | $0.70 | $0.06 | ||
| Q4 24 | $0.14 | $0.40 | ||
| Q3 24 | $0.28 | $0.41 | ||
| Q2 24 | $0.20 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $118.3M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.1B | $130.3M |
| 总资产 | $2.9B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资AATPBYI
| Q1 26 | $118.3M | — | ||
| Q4 25 | $129.4M | $97.5M | ||
| Q3 25 | $138.7M | $94.4M | ||
| Q2 25 | $143.7M | $96.0M | ||
| Q1 25 | $143.9M | $93.2M | ||
| Q4 24 | $425.7M | $101.0M | ||
| Q3 24 | $533.0M | $96.7M | ||
| Q2 24 | $114.9M | $96.8M |
总债务AATPBYI
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $2.0B | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益AATPBYI
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.2B | $130.3M | ||
| Q3 25 | $1.2B | $115.3M | ||
| Q2 25 | $1.2B | $104.7M | ||
| Q1 25 | $1.2B | $97.1M | ||
| Q4 24 | $1.2B | $92.1M | ||
| Q3 24 | $1.2B | $71.1M | ||
| Q2 24 | $1.2B | $48.5M |
总资产AATPBYI
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | $216.3M | ||
| Q3 25 | $2.9B | $202.9M | ||
| Q2 25 | $3.0B | $194.9M | ||
| Q1 25 | $3.0B | $196.2M | ||
| Q4 24 | $3.3B | $213.3M | ||
| Q3 24 | $3.4B | $220.7M | ||
| Q2 24 | $3.0B | $205.0M |
负债/权益比AATPBYI
| Q1 26 | — | — | ||
| Q4 25 | 1.48× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 1.72× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | 14.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流AATPBYI
| Q1 26 | — | — | ||
| Q4 25 | $167.1M | $14.4M | ||
| Q3 25 | $40.5M | $9.7M | ||
| Q2 25 | $49.2M | $14.1M | ||
| Q1 25 | $36.9M | $3.6M | ||
| Q4 24 | $207.1M | $15.6M | ||
| Q3 24 | $52.4M | $11.0M | ||
| Q2 24 | $59.3M | $1.0M |
自由现金流AATPBYI
| Q1 26 | — | — | ||
| Q4 25 | $94.9M | $14.4M | ||
| Q3 25 | $23.1M | $9.7M | ||
| Q2 25 | $28.4M | $14.1M | ||
| Q1 25 | $20.4M | $3.6M | ||
| Q4 24 | $136.9M | $15.6M | ||
| Q3 24 | $28.0M | $11.0M | ||
| Q2 24 | $43.6M | $1.0M |
自由现金流率AATPBYI
| Q1 26 | — | — | ||
| Q4 25 | 86.2% | 19.1% | ||
| Q3 25 | 21.1% | 17.7% | ||
| Q2 25 | 26.3% | 26.8% | ||
| Q1 25 | 18.8% | 7.7% | ||
| Q4 24 | 120.7% | 26.4% | ||
| Q3 24 | 22.8% | 13.7% | ||
| Q2 24 | 39.3% | 2.1% |
资本支出强度AATPBYI
| Q1 26 | 14.5% | — | ||
| Q4 25 | 65.6% | 0.0% | ||
| Q3 25 | 15.9% | 0.0% | ||
| Q2 25 | 19.3% | 0.0% | ||
| Q1 25 | 15.1% | 0.1% | ||
| Q4 24 | 61.9% | 0.0% | ||
| Q3 24 | 19.9% | 0.0% | ||
| Q2 24 | 14.1% | 0.0% |
现金转化率AATPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 8.98× | 1.10× | ||
| Q2 25 | 9.01× | 2.41× | ||
| Q1 25 | 0.87× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.15× | 0.54× | ||
| Q2 24 | 4.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AAT
| Rental income | $104.4M | 94% |
| Other | $6.2M | 6% |
PBYI
暂无分部数据
